SLC6A14 and gastric cancer: Additionally, upregulation of SLC6A14 expression has been observed in gastric cancer, and depletion of SLC6A14 leads to the suppression of epithelial-mesenchymal transition-induced metastasis in gastric cancer through disruption of the PI3K/Akt/mTORC1 pathway [60].